Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Parexel looks to new bookings as strategic partners reevaluate pipelines

Parexel has fallen short of its first quarter FY2017 expectations, but is encouraged by new business as it looks to "normalize" cancellation issues.

Envigo testing single wall carbon nanotubes

Envigo has collaborated with InterTek and OCSiAl to develop TUBALL™ single wall carbon nanotubes, which is the first of its kind to complete REACH registration.

eTMF market to grow sizably over next three years, ISR reports

The adoption of eTMF solutions is accelerating – with more than 50% of investigative sites expected to have access to a sponsor/CRO eTMF application within three years.

CFDA: reports of clinical trial data fraud 'not fact based'

The Chinese Food and Drug Administration (CDFA) has fired back on lack of context in media reporting “80% of China’s clinical trial data are fraudulent.”

Report: Australia 60% cheaper than US for clinical trials

With a tax incentive program making clinical trials up to 60% more cost-effective, Australia is a “gateway” to larger studies throughout Asia, says CRO.

Evotec announces intent to acquire preclinical CRO Cyprotex

Evotec has made an offer to acquire Cyprotex PLC, a preclinical contract research organization (CRO) specializing in ADME-Tox and DMPK.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...